Arabinogalactan (Larch)
A fermentable fiber with a small immune-marker file and one modest cold trial.
D+
Evidence grade
D
Worth it
$15-25/month
Typical cost
DoseThe cold trial used 4.5 g a day; supplements commonly run 1.5 to 4.5 g. No dose-response work exists.
BasisThe cold-incidence trial (a few hundred participants over a winter season) found fewer cold episodes against placebo, a single unreplicated result; immune-marker studies (vaccine-response and cell markers) are surrogates.
Arabinogalactan is a polysaccharide fiber from larch wood, fermented in the colon and marketed for immune support. We grade Arabinogalactan (Larch) D+ on evidence and D for worth-it at about $15-25 per month.
What it does
Arabinogalactan is a polysaccharide fiber from larch wood, fermented in the colon and marketed for immune support. Its human file is a handful of small studies on immune markers and one randomized trial on cold incidence.
What the research says
Reduces cold incidence
Evidence: emerging. One randomized trial at 4.5 g a day over 12 weeks of cold season reported fewer episodes; a single unreplicated study.
Supports immune function (marker claims)
Evidence: emerging. Small studies on vaccine antibody response and immune cell markers; surrogates, not illness outcomes.
The cold-incidence trial (a few hundred participants over a winter season) found fewer cold episodes against placebo, a single unreplicated result; immune-marker studies (vaccine-response and cell markers) are surrogates. Nothing else at outcome level exists. The plus marks a real trial where most records at this depth have none.
What the experts say
Every position links to its source. We include skeptics alongside supporters.
Listed in the Blueprint stack (arabinogalactan); basis takes, per the expert record.
Is it worth it?
At $15 to $25 a month it is the priciest record in this batch on the thinnest file; one unreplicated cold trial does not carry the price.
Typical cost
$15-25/month
Common form, not a brand recommendation
Dosage context emerging
The cold trial used 4.5 g a day; supplements commonly run 1.5 to 4.5 g. No dose-response work exists.
The worth-it ranking
Arabinogalactan (Larch) sits outside the worth-it ranking of 38.
Arabinogalactan (Larch) sits outside that ranking of 38. The leaders below clear an evidence floor of B- before price counts at all, so cheap alone never earns a rank.
- 1AWorth itCreatine evidence A-~$5-10/mo
- 2AWorth itCaffeine evidence B+~$5-10/mo
- 3AWorth itVitamin D evidence B~$5-8/mo
When the evidence moves a grade, this ranking moves with it. Thursday is where you hear it first.
Safety notes
Well tolerated in trials; mild gastrointestinal effects. Long-term data are thin because the whole file is thin.
Changelog
Last updated 2026-11-15
- 2026-11-15|Graded: single-trial cold claim graded at single-trial weight.
The week's longevity and biohacking news.
Every story graded against the evidence. Free. Unsubscribe anytime.
The week's longevity and biohacking news. Every story graded against the evidence. Free. Unsubscribe anytime.
Every grade follows a published rubric. Sponsors do not influence findings or grades.